MYCN and neuroblastoma: Combination treatment with JQ1 and Olaparib functioned synergistically against neuroblastoma tumorigenesis in both MYCN-amplifying and non-MYCN-amplifying cell lines when assessed quantitatively using the median-effect principle of Chou & Talalay